Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Zycband

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Anatomy|June 1, 1994
Assembly of the tendon extracellular matrix during developmentD E Birk, E Zycband
Diabetologia|November 30, 2006
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemiaS L Conarello, G Jiang, J Mu, et al.
Diabetologia|January 12, 2012
Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty ratM Futamura, J Yao, X Li, et al.
Diabetologia|June 23, 2011
Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese miceJ Mu, G Jiang, E Brady, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2016
Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ Di Salvo, H Nagabukuro, L A Wickham, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Anatomy|June 1, 1994
Assembly of the tendon extracellular matrix during developmentD E Birk, E Zycband
Diabetologia|November 30, 2006
Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemiaS L Conarello, G Jiang, J Mu, et al.
Diabetologia|January 12, 2012
Chronic treatment with a glucokinase activator delays the onset of hyperglycaemia and preserves beta cell mass in the Zucker diabetic fatty ratM Futamura, J Yao, X Li, et al.
Diabetologia|June 23, 2011
Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese miceJ Mu, G Jiang, E Brady, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2016
Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive BladderJ Di Salvo, H Nagabukuro, L A Wickham, et al.
Pageof 1